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154Endovascular repair of a mycotic thoracic aortic
aneurysm in a patient with aortic coarctation
Hany Hafez, MD, PhD, FRCS,a Reda Jamjoom, MD,a Elsayed Yuones, MD,a Zahid Khan, MD,b and
Majed Ashour, MD,b Jeddah, Saudi Arabia
This report describes the management of a 28-year-old female patient who presented with septicemia and mediastinal
mass-effect secondary to a proximal mycotic aneurysm of the descending aorta. The patient had an infected bicuspid aortic
valve, aortic coarctation, and a left vertebral artery arising directly from the aortic arch. Evidence of disseminated
embolization affecting her posterior cerebral circulation, the left axillary, and the superior mesenteric arteries was noted.
The patient had a considerably small aorta. An urgent thoracic endovascular aortic repair was performed successfully with
a chimney stent to the left vertebral artery. The report discusses the planning and technique used in managing this
complex case. (J Vasc Surg Cases 2015;1:154-6.)Bicuspid aortic valve (BAV) is the commonest congen-
ital cardiac anomaly. It affects between 1% and 2% of the
population.1 Up to 5% of individuals with BAV will also
have aortic coarctation (AC).2 Infective endocarditis (IE)
is a serious complication of BAV. IE will develop at some
stage in up to 30% of patients with BAV, with IE often being
the ﬁrst presentation of BAV. Men, young adults, and those
with regurgitant BAV are at an increased risk of developing
IE.1,3 Septic embolization is a known complication of IE
occurring in up to 50% of cases. However, for these emboli
to cause mycotic aneurysm formation is uncommon.4 Strep-
tococcus species are responsible for>50% of IE, with the oral
variety responsible for nearly 24% of cases.5
In this report, we present the management of what we
believe to be the ﬁrst case of a thoracic endovascular aortic
repair (TEVAR) in a patient with AC and a mycotic
thoracic aortic aneurysm (MAA). The patient gave full con-
sent for publishing her case.
CASE REPORT
A 28-year-old woman with BAV presented with septicemia in
the form of emaciation, hypotension, tachycardia, tachypnea, dys-
pnea, hypothermia, thrombocythemia, and leukocytosis. Her
erythrocyte sedimentation rate and C-reactive protein concentra-
tion were elevated. She also had progressive dysphagia and expres-
sive dysphasia with coordination impairment due to a posteriorthe Departments of Vascular and Endovascular Surgerya and
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entre.
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://dx.doi.org/10.1016/j.jvsc.2015.04.008circulation stroke. Computed tomography angiography showed a
saccular multiloccular aneurysm arising from the medial side of
the thoracic aorta immediately distal to an AC (Fig 1).
The aneurysm caused considerable narrowing to the esoph-
agus and complete occlusion of the left main bronchus leading
to a total collapse of the left lung. The aneurysm was deemed
mycotic based on the clinical assessment and radiologic images.
The patient also had a left vertebral artery (LVA) arising directly
from the aortic arch. In addition, she had an occluded left axillary
artery and occluded superior mesenteric artery. Transthoracic
echocardiography demonstrated a moderate aortic regurgitation
and pericardial effusion.
Results of blood cultures taken before antibiotics were admin-
istered were positive for Streptococcus salivarius. The patient had
two major and two minor modiﬁed Duke’s criteria for IE.6 Antibi-
otic therapy with intravenous meropenem was initiated and was
maintained throughout her hospital stay of 8 weeks. Results of
repeated blood cultures during this period were negative.
The TEVAR suitability assessment found the patient had a
number of challenging features. She had an angulated proximal
neck, which was short on the inner curvature. The maximum neck
diameter was 15mm at the origin of the left common carotid artery.
The distal landing zone was an adequate length but had a maximum
diameter of only 14.5 mm. The common femoral and external iliac
arteries were too small, in keeping with her AC history.
With these factors in mind, the choice of a TEVAR device was
challenging. We initially considered using the iliac limb of an
infrarenal device, which would have offered a better size match.
However, we excluded this option because these stents are not
designed to withstand the radial and longitudinal forces seen in
the aortic arch and could readily collapse if subjected to such pres-
sures. Instead, we opted for a TEVAR-speciﬁc device even when
this meant oversizing beyond the recommended range. Accord-
ingly, the patient underwent an urgent TEVAR using a size 21
C-TAG device (W. L. Gore and Associates, Flagstaff, Ariz)
crossing the origin of the left subclavian artery (LSA). A
5-mm 22-mm Advanta (Atrium Medical Corp, Hudson, NH)
chimney stent was placed in the LVA.
Access was achieved via extraperitoneal exposure of the right
common iliac artery and percutaneous right brachial artery punc-
ture. Although the contralateral antegrade access to the LVA
Fig 1. A, Preoperative volume-rendered reconstruction and (B) computed tomography angiography show (I) left
vertebral artery (LVA), (II) aortic coarctation (AC), and (III) complex mycotic aortic aneurysm (MAA).
Fig 2. Volume-rendered postoperative computed tomography
angiography shows complete isolation of the mycotic aneurysm
sac.
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operative stroke, this was the only available access route and the
only feasible revascularization option in this patient. The AC was
balloon dilated from within the stent graft. The aneurysm sac
was excluded completely on completion angiography and at
3 months postprocedure (Fig 2).
After TEVAR, the left lung expanded fully, and the patient’s
dysphagia resolved. Her body mass index increased from
12.9 kg/m2 on admission to 17.8 kg/m2 at 4 weeks post-TEVAR.
The patient underwent an uneventful aortic valve replacement
surgery 6 weeks after the MAA repair. She made a considerable
neurologic improvement and was discharged home on a 6-month
course of oral azithromycin, life-long full anticoagulation, sepsis
screening (white cell count, C-reactive protein) every 4 months,
outpatient follow-up every 6 months, and transthoracic echocardi-
ography and yearly computed tomography imaging.
DISCUSSION
MAAs are a challenging clinical entity. Patients with
this condition often present as an emergency with poor
general health due to the associated sepsis. Although the
MAA diagnosis is often straightforward, the choice of
open or endovascular surgical intervention is usually deter-
mined case-by-case. Owing to the rarity of this condition,
all the available evidence for MAA management comes
from case series. By nature, these tend to reﬂect the man-
agement preferences of a single surgeon or center and their
conclusions cannot therefore be generalized. A number of
relatively large such series showed open surgery provided
reasonably good long-term outcomes.7,8 In the meantime,
TEVAR experience continues to build up, with some
recent reports showing equally good results.9,10 However,
TEVAR does not allow the removal of infected tissues, and
concern remains regarding the infection-free durability of
such a repair.11The patient in this report required two major interven-
tions, namely, aortic valve replacement and MAA repair.
With an American Society of Anesthesiology Physical Status
Classiﬁcation score of 4, openMAA repair was ruled out.We
were still left with the difﬁcult choice of inserting a consider-
ably oversized stent graft in an aortic segment that was both
aneurysmal and constricted and with a hostile aneurysm
neck. This task required a device with good conformability.
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particularly because it can be oversized by up to 33%.
Covering the origin of the LSA was necessary to obtain
an adequate proximal seal on the inner curvature. Although
we would routinely revascularize the LSA,12 we decided
against doing so in this particular patient because the ipsi-
lateral axillary artery was occluded and the origin of the
LVA was from the aortic arch directly. We therefore opted
to revascularize the LVA only. The main concern of
covering the LSA in this patient was the interruption of
blood supply to the well-developed left internal mammary
artery. However, we assumed that dilating the AC would
compensate for this. By opting not to revascularize the
LSA, we took the risk of having a type II endoleak from
this vessel. This risk did not outweigh the beneﬁt of no
intervention. Had a type II endoleak developed from the
LSA, this would have been potentially amenable to Onyx
(ev3 Endovascular Inc, Plymouth, Minn) or coil emboliza-
tion via direct puncture or surgical ligation if necessary.
Although some centers continue to offer open surgery
for AC in adults with good results,13 balloon angioplasty is
now an established treatment method for AC in this age
group. The combination of balloon angioplasty and stent-
ing improves the durability of pressure gradient reduction
compared with angioplasty alone.14,15 In our patient, we
decided against prestenting angioplasty of the AC because
the risk of aortic rupture was high. Instead, we performed
within-stent angioplasty.
The chimney technique is a useful tool for maintaining
visceral or arch vessel perfusion during endovascular aortic
stenting. The method is technically demanding but lends
itself to emergency situations where rapid endovascular
intervention is required. This technique has a proven
high short-term success.16 Intermediate-term and long-
term data regarding its durability are now coming through,
with some centers reporting good results.17
Graft collapse is a recognized complication of thoracic
aortic endograft oversizing. The risk is particularly high
when low radial force devices are used. The Gore TAG
was one such device for which relatively high collapse rates
had been reported.18 Graft collapse tends to occur
#30 days from the insertion of grafts that are oversized
by >23%.19 Although we used the smallest available size,
the C-TAG device we used was still oversized by 40%.
However, the C-TAG device has a superior radial force
and radial ﬁt compared with its predecessor and has per-
formed well to date in this particular patient.
CONCLUSIONS
A number of endovascular techniques were used to
manage this complex and rare presentation of a thoracic
MAA in a patient with AC and aberrant arch anatomy.
Although long-term device durability and infection-free
survival in this patient remain to be seen, she has at least
survived the acute phase of her disease. We are not planning
to offer this patient open surgery at this stage. However, she
has now recovered sufﬁciently to be considered for such an
intervention should it become necessary in the future.REFERENCES
1. Fedak PW, Verma S, David TE, Leask RL, Weisel RD, Butany J.
Clinical, pathophysiological implications of a bicuspid aortic valve.
Circulation 2002;106:900-4.
2. Franco-Paredes C, Workowski K, Harris M. Infective endocarditis-
endarteritis complicating coarctation of the aorta. Am J Med
2002;112:590-2.
3. Lamas CC, Eykyn SJ. Bicuspid aortic valveda silent danger: analysis of
50 cases of infective endocarditis. Clin Infect Dis 2000;30:336-41.
4. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF,
Levison ME, et al. Infective endocarditis: diagnosis, antimicrobial
therapy, and management of complications: a statement for healthcare
professionals from the Committee on Rheumatic Fever, Endocarditis,
and Kawasaki Disease, Council on Cardiovascular Disease in the
Young, and the Councils on Clinical Cardiology, Stroke, and Cardio-
vascular Surgery and Anesthesia, American Heart Association: endorsed
by the Infectious Diseases Society of America. Circulation 2005;111:
e394-434.
5. Duval X, Delahaye F, Alla F, Tattevin P, Obadia JF, Le Moing V, et al.
Temporal trends in infective endocarditis in the context of prophylaxis
guideline modiﬁcations. J Am Coll Cardiol 2012;59:1968-76.
6. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al.
Proposed modiﬁcations to the Duke criteria for the diagnosis of
infective endocarditis. Clin Infect Dis 2000;30:633-8.
7. Dubois M, Daenens K, Houthoofd S, Peetermans WE, Fourneau I.
Treatment of mycotic aneurysms with involvement of the abdominal
aorta: single-centre experience in 44 consecutive cases. Eur J Vasc
Endovasc Surg 2010;40:450-6.
8. Weis-Müller BT, Rascanu C, Sagban A, Grabitz K, Godehardt E,
Sandmann W. Single-center experience with open surgical treatment of
36 infected aneurysms of the thoracic, thoracoabdominal, abdominal
aorta. Ann Vasc Surg 2011;25:1020-5.
9. Sörelius K, Mani K, Björck M, Nyman R, Wanhainen A. Endovas-
cular repair of mycotic aortic aneurysms. J Vasc Surg 2009;50:
269-74.
10. Patel HJ, Williams DM, Upchurch GR Jr, Dasika NL, Eliason JL,
Deeb GM. Late outcomes of endovascular aortic repair for the infected
thoracic aorta. Ann Thorac Surg 2009;87:1366-72.
11. Clough RE, Black SA, Lyons OT, Zayed HA, Bell RE, Carrell T, et al.
Is endovascular repair of mycotic aortic aneurysms a durable treatment
option? Eur J Vasc Endovasc Surg 2009;37:407-12.
12. Matsumura JS, Lee WA, Mitchell RS, Farber MA, Murad MH,
Lumsden AB, et al. The Society for Vascular Surgery Practice Guide-
lines: management of the left subclavian artery with thoracic endovas-
cular aortic repair. J Vasc Surg 2009;50:1155-8.
13. Charlton-Ouw KM, Codreanu ME, Leake SS, Sandhu HK,
Calderon D, Azizzadeh A, et al. Open repair of adult aortic coarctation
mostly by a resection, graft replacement technique. J Vasc Surg
2015;61:66-72.
14. Zabal C. The adult patient with native coarctation of the aorta: balloon
angioplasty or primary stenting? Heart 2003;89:77-83.
15. Harris KC, Du W, Cowley CG, Forbes TJ, Kim DW; Congenital
Cardiac Intervention Study Consortium (CCISC). A prospective
observational multicenter study of balloon angioplasty for the treat-
ment of native, recurrent coarctation of the aorta. Catheter Cardiovasc
Interv 2013;83:1116-23.
16. Hogendoorn W, Schlösser FJ, Moll FL, Sumpio BE, Muhs BE.
Thoracic endovascular aortic repair with the chimney graft technique.
J Vasc Surg 2013;58:502-11.
17. Bin Jabr A, Lindblad B, Dias N, Resch T, Malina M. Efﬁcacy and
durability of the chimney graft technique in urgent and complex
thoracic endovascular aortic repair. J Vasc Surg 2015;61:886-94.e1.
18. Jonker FH, Schlosser FJ, Geirsson A, Sumpio BE, Moll FL, Muhs BE.
Endograft collapse after thoracic endovascular aortic repair. J Endovasc
Ther 2010;17:725-34.
19. Tadros RO, Lipsitz EC, Chaer RA, Faries PL, Marin ML, Cho JS.
A multicenter experience of the management of collapsed thoracic
endografts. J Vasc Surg 2011;53:1217-22.
Submitted Feb 17, 2015; accepted Apr 16, 2015.
